drugset / Trial / NCT07694947

Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

NCT07694947 ↗

Completed 100 enrolled Mansoura University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Asthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent airway inflammation and disease heterogeneity.

Timeline

Start
2023-01-01
Primary completion
2023-07-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Allergen Immunotherapy Extract Vaccine — Subcutaneous

Indications